
Predicta Biosciences provides blood-based, multiomic diagnostics that enable personalized treatment guidance and high-resolution monitoring for hematologic cancers. The company combines liquid…

Predicta Biosciences provides blood-based, multiomic diagnostics that enable personalized treatment guidance and high-resolution monitoring for hematologic cancers. The company combines liquid…
Location & focus: Boston-based diagnostics company focused on WGS-based cellular liquid biopsy for multiple myeloma and plasma cell dyscrasias
Flagship product: GenoPredicta — whole-genome sequencing-based clinical assay for blood and bone marrow
Use cases: Noninvasive disease monitoring, treatment decision support for immunotherapies, and discovery of immunotherapy targets
Founding year: 2023
Recent funding: Series A (Oct 2025); reported round about $23.4M; total funding reported ~$28.6M
Diagnostics and monitoring for hematologic cancers (multiple myeloma and plasma cell dyscrasias); precision oncology and immunotherapy target discovery.
2023
Biotechnology Research
23,400,000
Dealroom reports Series A amount $23.4M; Crunchbase lists Engine Ventures as lead
“Backed by life-sciences and strategic investors including Engine Ventures, Illumina Ventures, Mass General Brigham Ventures, Binney Street Capital and others”
| Company |
|---|
Predicta Biosciences is a precision oncology company that integrates cutting-edge multiomics and liquid biopsies to create innovative diagnostic and therapeutic products. By eliminating the need for invasive bone-marrow biopsies and using small blood-based samples, Predicta enhances immunotherapy treatment decision-making. Additionally, Predicta has developed an in-house therapeutic pipeline focused on novel immunotherapy targets in pre-clinical discovery and development.
As we expand our clinical testing capabilities, we are seeking highly skilled and motivated Clinical Lab Scientists (I/II/III) to join our team. The ideal candidate will bring strong technical expertise, thrive in a dynamic startup environment, and play a key role in delivering impactful diagnostic results that drive better patient outcomes.
Key Responsibilities:
Qualifications:
Work Location
This role is based in Cambridge, MA and is an full time in-office role. Travel or potential relocation to North Carolina in the future may be required.
Why Join Predicta Biosciences?
This is a unique opportunity to be part of a mission-driven team advancing precision diagnostics for hematologic cancers. You’ll play a key role in shaping the quality and performance of our clinical testing efforts and contribute directly to patient-impactful innovations.
The annual salary range for this position is $65,000 - $100,000 plus a 10% bonus opportunity. Predicta considers a variety of factors when determining base compensation, including experience, skills, education, qualifications, and geographic location. Actual compensation will vary, and it is not typical to be hired at or near the top of the range for the role. Additional rewards include equity, flexible time off, 401k Plan, medical, dental and vision plans that are 90% paid by Predicta and a partially company funded HSA.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week